Promega, Life Tech Both Urge Fed. Circ. To Review IP Ruling
Law360, New York (January 16, 2015, 2:57 PM EST) -- Promega Corp. and Life Technologies Corp. have lodged dueling petitions each urging the Federal Circuit on Wednesday to review portions of its decision to undo a federal judge's order vacating Promega's $52 million patent win over the alleged infringement of its gene-testing technology while still invalidating all but one of Promega's asserted patents.
Both entities filed petitions on Wednesday, seeking a review of a December ruling by a split Federal Circuit panel, which remanded the case back to trial court to determine damages stemming from the infringement of Promega's lone remaining patent, one of five asserted in the case. The panel's...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!